VT8-32336-90893
5 vaccinations
2 coded responses
23 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 480 / MI
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Dose 1 — Moderna
-
2021-04-02
Registered in v-safe
- 2021-04-02
- 2021-04-08
-
2021-04-15
Dose 2 — Moderna
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-15
- 2021-10-14
-
2021-11-29
Dose 3 — Moderna
-
2022-04-15
Survey response — 12 months, dose 2MedDRA: Cough, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose, sore throat, fever, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-09
Dose 4 — Moderna
-
2022-10-28
Dose 5 — Pfizer-BioNTech
- 2022-10-28
- 2022-10-29
-
2022-10-30
Survey response — days 1–6 daily, dose 5MedDRA: Rhinorrhoea, Sneezing — Feeling: GoodFree text: Sneezing/runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-11-01
- 2022-11-03
- 2022-11-04
- 2022-11-20
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2023-01-29
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Moderna | |
| 2 | 2021-04-15 | Moderna | |
| 3 | 2021-11-29 | Moderna | No |
| 4 | 2022-06-09 | Moderna | No |
| 5 | 2022-10-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-15 | Successful 2022-04-19 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 12 months, dose 2
Symptoms: Runny nose, sore throat, fever, cough
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Sneezing/runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release